Reactivation of Hepatitis B Virus Infection - an Important Aspect of Multifaceted Problem

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2024 Aug 1

PMID 39086636

Authors

Sergey Morozov

Sergey Batskikh

Affiliations

Soon will be listed here.

Abstract

In this editorial we comment on the article published in the recent issue of the W. We focus specifically on the problem of occult hepatitis B virus (HBV) infection, that is a result of previous hepatitis B (PHB) and a source for reactivation of HBV. The prevalence of PHB is underestimated due to the lack of population testing programs. However, this condition not only complicate anticancer treatment, but may be responsible for the development of other diseases, like cancer or autoimmune disorders. Here we unveil possible mechanisms responsible for realization of these processes and suggest practical approaches for diagnosis and treatment.

References

Ng K, Chai S, Tong M, Guan X, Lin C, Ching Y . C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties. Oncotarget. 2016; 7(17):24005-17. PMC: 5029680. DOI: 10.18632/oncotarget.8209. View

Wang Y, Zeng L, Chen W . HBV X gene point mutations are associated with the risk of hepatocellular carcinoma: A systematic review and meta-analysis. Mol Clin Oncol. 2016; 4(6):1045-1051. PMC: 4888003. DOI: 10.3892/mco.2016.847. View

Budzinska M, Shackel N, Urban S, Tu T . Cellular Genomic Sites of Hepatitis B Virus DNA Integration. Genes (Basel). 2018; 9(7). PMC: 6071206. DOI: 10.3390/genes9070365. View

Coppola N, Onorato L, Sagnelli C, Sagnelli E, Angelillo I . Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: A meta-analysis. Medicine (Baltimore). 2016; 95(30):e4311. PMC: 5265845. DOI: 10.1097/MD.0000000000004311. View

Mak J, Law A, Law K, Ho R, Cheung C, Law M . Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era. World J Gastroenterol. 2023; 29(33):4942-4961. PMC: 10507505. DOI: 10.3748/wjg.v29.i33.4942. View

Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M . Control of cccDNA function in hepatitis B virus infection. J Hepatol. 2009; 51(3):581-92. DOI: 10.1016/j.jhep.2009.05.022. View

Terrault N, Lok A, McMahon B, Chang K, Hwang J, Jonas M . Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018; 67(4):1560-1599. PMC: 5975958. DOI: 10.1002/hep.29800. View

Yeo D, Hossain I, Lim S, Farid M, Tao M, Quek R . Management of hepatitis B reactivation in lymphoma patients on rituximab with past hepatitis B exposure: An observational study. J Oncol Pharm Pract. 2018; 25(5):1042-1052. DOI: 10.1177/1078155218763039. View

. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017; 67(2):370-398. DOI: 10.1016/j.jhep.2017.03.021. View

10.

Lok A, Everhart J, Di Bisceglie A, Kim H, Hussain M, Morgan T . Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C. Hepatology. 2011; 54(2):434-42. PMC: 3134544. DOI: 10.1002/hep.24257. View

11.

Colapietro F, Pugliese N, Voza A, Aghemo A, De Nicola S . Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis. World J Gastroenterol. 2024; 30(9):1253-1256. PMC: 10989482. DOI: 10.3748/wjg.v30.i9.1253. View

12.

Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M . Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res. 2001; 61(21):7803-10. View

13.

Wang D, Cai H, Yu W, Yu L . Identification of hepatitis B virus X gene variants between hepatocellular carcinoma tissues and pericarcinoma liver tissues in Eastern China. Int J Clin Exp Pathol. 2014; 7(9):5988-96. PMC: 4203214. View

14.

Batskikh S, Morozov S, Dorofeev A, Borunova Z, Kostyushev D, Brezgin S . Previous hepatitis B viral infection-an underestimated cause of pancreatic cancer. World J Gastroenterol. 2022; 28(33):4812-4822. PMC: 9476854. DOI: 10.3748/wjg.v28.i33.4812. View

15.

Wang Q, Klenerman P, Semmo N . Significance of anti-HBc alone serological status in clinical practice. Lancet Gastroenterol Hepatol. 2017; 2(2):123-134. DOI: 10.1016/S2468-1253(16)30076-0. View

16.

Iossa D, Vitrone M, Liotti A, Portella G, Durante-Mangoni E, Zampino R . Hepatitis B core-related antigen to detect hepatitis B virus (HBV) reactivation in heart transplant recipients with past HBV infection: A pilot study. Clin Transplant. 2019; 33(6):e13574. DOI: 10.1111/ctr.13574. View

17.

Smatti M, Cyprian F, Nasrallah G, Al Thani A, Almishal R, Yassine H . Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms. Viruses. 2019; 11(8). PMC: 6723519. DOI: 10.3390/v11080762. View

18.

Tarocchi M, Polvani S, Marroncini G, Galli A . Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis. World J Gastroenterol. 2014; 20(33):11630-40. PMC: 4155355. DOI: 10.3748/wjg.v20.i33.11630. View

19.

Luo G, Hao N, Hu C, Yong X, Lu M, Cheng B . HBV infection increases the risk of pancreatic cancer: a meta-analysis. Cancer Causes Control. 2013; 24(3):529-37. DOI: 10.1007/s10552-012-0144-2. View

20.

Liu S, Koh S, Lee C . Hepatitis B Virus X Protein and Hepatocarcinogenesis. Int J Mol Sci. 2016; 17(6). PMC: 4926473. DOI: 10.3390/ijms17060940. View